Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The Journal of Headache and Pain
Published in: The Journal of Headache and Pain 1/2014

Open Access 01-12-2014 | Meeting abstract

EHMTI-0262. Dysregulation of inflammatory pathways in a familial hemiplegic migraine 1 mouse model after the induction of cortical spreading depression

Authors: B de Vries, EE Eising, R Shyti, LS Vijfhuizen, LAM Broos, PAC’t Hoen, MD Ferrari, EA Tolner, AMJM van den Maagdenberg

Published in: The Journal of Headache and Pain | Special Issue 1/2014

Login to get access

Excerpt

Familial Hemiplegic Migraine type 1 (FHM1) is a rare monogenic subtype of migraine with aura caused by mutations in the CACNA1A gene. In FHM1 knock-in mouse models these mutations increase the susceptibility for cortical spreading depression (CSD): the underlying mechanism of the migraine aura. …
Metadata
Title
EHMTI-0262. Dysregulation of inflammatory pathways in a familial hemiplegic migraine 1 mouse model after the induction of cortical spreading depression
Authors
B de Vries
EE Eising
R Shyti
LS Vijfhuizen
LAM Broos
PAC’t Hoen
MD Ferrari
EA Tolner
AMJM van den Maagdenberg
Publication date
01-12-2014
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue Special Issue 1/2014
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1186/1129-2377-15-S1-B5

Other articles of this Special Issue 1/2014

The Journal of Headache and Pain 1/2014 Go to the issue

Meeting abstract

EHMTI-0271. Refractory chronic daily headache and idiopathic intracranial hypertension: preliminary results of a prospective study

Meeting abstract

EHMTI-0133. Does medication overuse matter? Response to botulinum toxin type A in chronic migraine in patients with or without medication overuse

Meeting abstract

EHMTI-0333. The prevalence and burden of migraine in india: results of a population-based study in Karnataka state

Meeting abstract

EHMTI-0166. Chronic daily headace-impact of adverse childhood experiences

Meeting abstract

EHMTI-0178. CGRP monoclonal antibody LY2951742 for the prevention of migraine: a phase 2, randomized, double-blind, placebo-controlled study

Meeting abstract

EHMTI-0326. OnabotulinumtoxinA for the treatment of chronic paroxysmal hemicrania: a case report